000			02049nam a2200445 i 4500
999			_c287547 _d287547
001			on1114600100
003			OCoLC
005			20191009101114.0
006			m o d f
007			cr bn|||||||||
008			190830s2019 dcu o f000 0 eng c
040			_aPUCPR _beng _erda _epn _cGPO _dMvI
042			_apcc
043			_an-us---
074			_a1016-C (online)
086	0		_aY 4.OV 2:116-35
088			_aSerial no. 116-35 (United States. Congress. House. Committee on Oversight and Reform)
099			_aY 4.OV 2:116-35
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Oversight and Reform,
245	1	0	_aMedical experts : _binadequate federal approach to opioid treatment and the need to expand care : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, June 19, 2019.
246	3	0	_aInadequate federal approach to opioid treatment and the need to expand care
264		1	_aWashington : _bU.S. Government Publishing Office, _c2019.
300			_a1 online resource (iii, 52 pages)
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
500			_a"Serial no. 116-35."
500			_aCRDP Program record.
588			_aDescription based on online resource; title from PDF title page (govinfo, viewed Aug. 30, 2019).
776	0	8	_iPrint version: _aUnited States. Congress. House. Committee on Oversight and Reform. _tMedical experts _w(OCoLC)1114335293
856	4	0	_3PDF version _uhttps://purl.fdlp.gov/GPO/gpo125049
856	4	0	_3Text version _uhttps://purl.fdlp.gov/GPO/gpo125050
050		4	_aKF27 _b.O96 2019n
650		0	_aOpioids _xOverdose _zUnited States _xPrevention.
650		0	_aOpioid abuse _xTreatment _xGovernment policy _zUnited States.
650		0	_aDrug addiction _xTreatment _xGovernment policy _zUnited States.
650		0	_aDrugs _xPrescribing _xGovernment policy _zUnited States.
655		7	_aLegislative hearings. _2lcgft
942			_2sudocs _c8